シンバイオ製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4582/E24682-
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2017/06/23日証協無担保126,300株0%0株0%770,784株-7%
2017/06/23日証協有担保5,355,100株+18.55%1,130,100株+37.15%2,210,500株+13.58%
2017/06/16日証協無担保0株0%0株0%828,844株-4.93%
2017/06/16日証協有担保4,517,100株+10.03%824,000株+50.69%1,946,200株+3.64%
2017/06/09日証協無担保0株0%0株0%871,788株+0.65%
2017/06/09日証協有担保4,105,500株+4.82%546,800株-23.51%1,877,800株+25.71%
2017/06/02日証協無担保0株0%0株0%866,188株-0.33%
2017/06/02日証協有担保3,916,900株-10.66%714,900株+7.09%1,493,800株-24.93%
2017/05/26日証協無担保0株0%0株0%869,088株-2.94%
2017/05/26日証協有担保4,384,500株-0.24%667,600株-3.26%1,989,800株+0.25%
2017/05/19日証協無担保0株0%0株0%895,443株+1.9%
2017/05/19日証協有担保4,395,200株+4.73%690,100株-6.12%1,984,800株+5.44%
2017/05/12日証協無担保0株0%0株0%878,743株-4.1%
2017/05/12日証協有担保4,196,500株+1.04%735,100株-1.54%1,882,400株+2.09%
2017/05/02日証協無担保0株0%0株0%916,343株+4.53%
2017/05/02日証協有担保4,153,500株-1.5%746,600株-7.75%1,843,800株-0.02%
2017/04/28日証協無担保0株0%0株0%876,643株-0.05%
2017/04/28日証協有担保4,216,800株+1.6%809,300株+5.79%1,844,100株+0.6%
2017/04/21日証協無担保0株0%0株0%877,043株+1.33%
2017/04/21日証協有担保4,150,500株+1.93%765,000株-2.96%1,833,100株+1.91%
2017/04/14日証協無担保0株0%0株0%865,543株+1.38%
2017/04/14日証協有担保4,071,900株-0.23%788,300株+1.36%1,798,700株-0.99%
2017/04/07日証協無担保0株0%0株0%853,743株+8.44%
2017/04/07日証協有担保4,081,400株+6.15%777,700株+36.46%1,816,700株+0.69%
2017/03/31日証協無担保0株0%0株0%787,300株-4.23%
2017/03/31日証協有担保3,845,000株-1.94%569,900株+6.11%1,804,200株-1.98%
2017/03/24日証協無担保0株0%0株0%822,046株+0.98%
2017/03/24日証協有担保3,921,100株-1.43%537,100株-0.54%1,840,600株-3.27%
2017/03/17日証協無担保0株0%0株0%814,088株-1.58%
2017/03/17日証協有担保3,977,800株-1.65%540,000株-4.66%1,902,900株-1.43%
2017/03/10日証協無担保0株0%0株0%827,188株-0.49%
2017/03/10日証協有担保4,044,500株-8.25%566,400株+9.51%1,930,600株-6.13%
2017/03/03日証協無担保0株0%0株0%831,288株+1.58%
2017/03/03日証協有担保4,408,000株-0.54%517,200株+65.19%2,056,700株+0.66%
2017/02/24日証協無担保0株0%0株0%818,388株+0.69%
2017/02/24日証協有担保4,431,800株+3.59%313,100株-33.03%2,043,200株+1.07%
2017/02/17日証協無担保0株0%0株0%812,788株+3.98%
2017/02/17日証協有担保4,278,100株-9.98%467,500株+12.54%2,021,500株-11.11%

※株式分割は考慮していませんのでご注意ください。

Page Top